HealthNovartis Drug Kisqali Boosts Survival Rate Of Young Breast Cancer Patients Clinical trials featuring Novartis' Kisqali revealed the potential of the drug to extend the life of breast cancer patients. Results showed that when Kisqali was used along with hormone therapy, it could increase survival rates by 70.2 percent.by Ted Ranosa
HealthKentucky Toddler Jackson Oblisk Falls Into Coma After A Tick Bite: Here Are The Symptoms Of Rocky Mountain Spotted Feverby Naia Carlos
HealthMidday Naps Lead To Happy Children With Higher IQs, Improved Academic Performancesby Naia Carlos
Health27-Year-Old Chelsie Thomas Left Infertile After Surgeon Mistakenly Removed Healthy Fallopian Tubeby Ted Ranosa
10 Hidden Android Tricks and Settings Tips in Android 2025 That Instantly Boost Your Phone Experience